Chelation therapy in β-thalassemia major. III. The role of splenectomy in achieving iron balance
Authors:
- Joseph H. GrazianoJGJoseph H. Graziano
- Sergio PiomelliSPSergio Piomelli
- Margaret HilgartnerMHMargaret Hilgartner
- Patricia GiardinaPGPatricia Giardina
- Margaret KarpatkinMKMargaret Karpatkin
- Maureen AndrewMAMaureen Andrew
- Nancy LoIaconoNLNancy LoIacono
- Carol SeamanCSCarol Seaman
- 1 November 1981
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 99 (5) , 695-699
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Transfusion requirements and splenectomy in thalassemia majorThe Journal of Pediatrics, 1980
- Cooley anemia: High transfusion regimen and chelation therapy, results, and perspectiveThe Journal of Pediatrics, 1978
- Chelation therapy in β-thalassemia major. I. Intravenous and subcutaneous deferoxamineThe Journal of Pediatrics, 1978
- Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron OverloadNew England Journal of Medicine, 1977
- Total management of thalassaemia major.Archives of Disease in Childhood, 1977
- Thalassemia Major: A Problem of Iron OverloadAnnals of Internal Medicine, 1974
- HYPERTRANSFUSION REGIMEN IN PATIENTS WITH Cooley's ANEMIA*Annals of the New York Academy of Sciences, 1974
- PREVENTION OF BONE MALFORMATIONS AND CARDIOMEGALY IN COOLEY'S ANEMIA BY EARLY HYPERTRANSFUSION REGIMEN*Annals of the New York Academy of Sciences, 1969
- Transfusion Therapy in Cooley's Anemia: Growth and Health as Related to Long‐Range Hemoglobin Levels. A Progress ReportAnnals of the New York Academy of Sciences, 1964
- Relationship of Erythrocyte Survival and Reticulocyte Levels to Splenectomy and Need for Transfusion in Thalassemia Major*Annals of the New York Academy of Sciences, 1964